VXL.V - Vaxil Bio Ltd.

TSXV - TSXV Real Time Price. Currency in CAD
0.0000 (0.00%)
At close: 12:06PM EDT
Stock chart is not supported by your current browser
Previous Close0.0150
Bid0.0150 x 0
Ask0.0200 x 0
Day's Range0.0200 - 0.0200
52 Week Range0.0100 - 0.0400
Avg. Volume37,651
Market Cap2.055M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Vaxil’s Annual and Special Shareholders Meeting

    Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 24, 2023 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, announces that at the Company's Annual and Special General Meeting, held virtually, on April 20, 2023, all resolutions were duly passed by shareholders. ABOUT VAXIL Vaxil is an Israeli immunotherapy biotech company focused on its novel